Powerpoint Slide

Created/designed by Nina Chamlou for Monster Academy “The Write Path: Introduction to Medical Writing in Pharma” course for portfolio purposes.

Purpose:

  1. To summarize clinical trial results from the MONARCH study comparing sarilumab vs. adalimumab monotherapy in rheumatoid arthritis patients.

  2. To communicate the study design, endpoints, and outcomes clearly and concisely.

  3. To support scientific or promotional discussions about the benefits of sarilumab as a monotherapy option.